Psoriasis is a clinically heterogeneous lifelong skin disease that presents in multiple forms
such as plaque, flexural, guttate, pustular or erythrodermic. An estimated 60 million people …

Psoriasis is a chronic, inflammatory, immune‐mediated skin disease associated with
substantial comorbidity. Traditional comorbid conditions include psychological/psychiatric …

Psoriasis is an inflammatory skin disease that affects 1–3% of Caucasian populations and
may be persistent, disfiguring and stigmatising. There is a range of severity, but even when …

In times of targeted therapies, innovative therapeutics become tools to further unravel the
pathogenesis of the treated disease, thus influencing current pathogenetic concepts. Based …

The aetiology of psoriasis is still unclear but our knowledge of the psoriatic process has
grown substantially over the last two decades. The future will undoubtedly bring advances in …

Importance Approximately 125 million people worldwide have psoriasis. Patients with
psoriasis experience substantial morbidity and increased rates of inflammatory arthritis …

Psoriasis is a common skin disorder affecting the population worldwide. It is a T-cell
mediated autoimmune disorder leading to keratinocyte hyperproliferation. Psoriasis has …

The management of psoriasis has evolved considerably over the past 100 years. This has
occurred in parallel with our understanding of the pathogenesis of this common, complex …

Background Psoriasis is a chronic, systemic immune‐mediated disease characterized by
development of erythematous, indurated, scaly, pruritic and often painful skin plaques …

Over the last decade, the management of psoriasis has witnessed a paradigm shift. Thanks
to the increasing knowledge about the pathogenesis of psoriasis, targeted treatments with …